TREM2 and cholesteatoma: In acquired cholesteatoma, there is an increased expression of inflammatory cytokines, including IL-1β, TNF-α, and IL-6, as well as matrix metalloproteinases MMP-2, MMP-8, and MMP-9, that is positively associated with the elevated levels of TREM2 (44).